AHCO vs PHG

For growth investors, AdaptHealth Corp.

(AHCO) is the stronger pick with -0. 5% revenue growth year-over-year, versus -1. 0% for Koninklijke Philips N. V. (PHG). Koninklijke Philips N. V. (PHG) offers the better valuation at 24. 9x trailing P/E (17. 5x forward), making it the more compelling value choice. Analysts rate AdaptHealth Corp. (AHCO) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, AdaptHealth Corp.

is actually cheaper at 11. 7x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Koninklijke Philips N.

V. (PHG) delivered a total return of -42. 7%, compared to -55. 5% for AdaptHealth Corp. (AHCO). Over 10 years, the gap is even starker: PHG returned +48. 3% versus AHCO's +20. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), AdaptHealth Corp.

(AHCO) is the lower-risk stock at 0. 83β versus Koninklijke Philips N. V. 's 1. 12β — meaning PHG is approximately 35% more volatile than AHCO relative to the S&P 500. On balance sheet safety, Koninklijke Philips N. V. (PHG) carries a lower debt/equity ratio of 74% versus 125% for AdaptHealth Corp. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), AdaptHealth Corp.

(AHCO) is pulling ahead at -0. 5% versus -1. 0% for Koninklijke Philips N. V. (PHG). On earnings-per-share growth, the picture is similar: Koninklijke Philips N. V. grew EPS 224. 0% year-over-year, compared to -185. 2% for AdaptHealth Corp.. Over a 3-year CAGR, AHCO leads at 3. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Koninklijke Philips N.

V. (PHG) is the more profitable company, earning 5. 0% net margin versus -2. 2% for AdaptHealth Corp. — meaning it keeps 5. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PHG leads at 8. 0% versus 5. 7% for AHCO. At the gross margin level — before operating expenses — PHG leads at 45. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, AdaptHealth Corp.

(AHCO) trades at 11. 7x forward P/E versus 17. 5x for Koninklijke Philips N. V. — 5. 8x cheaper on a one-year earnings basis.

In this comparison, PHG (1.

5% yield) pays a dividend. AHCO does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Koninklijke Philips N.

V. (PHG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 12), 1. 5% yield). Both have compounded well over 10 years (PHG: +48. 3%, AHCO: +20. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

PHG pays a dividend while AHCO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.